Julien Blanc

Julien Blanc

Auto-generated profile, based on publicly available information

Julien Blanc

Lausanne University Hospital

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JBJulien Blanc
Julien Blanc
ILIsabella Locatelli
Isabella Locatelli
PRPatricia Rarau
Patricia Rarau
IMIvo Mueller
Ivo Mueller
BGBlaise Genton
Blaise Genton
NSNicolas Senn
Nicolas Senn
This secondary analysis of data of a randomized controlled trial (RCT) retrospectively investigated the performance of pulse oximetry in identifying children with severe illnesses, with and without respiratory signs/symptoms, in a cohort of children followed for morbid episodes in an intervention trial assessing the efficacy of Intermittent Preventive Treatment for malaria in infants (IPTi) in Papua New Guinea (PNG) from June 2006 to May 2010. The IPTi study was conducted in a paediatric population visiting two health centres on the north coast of PNG in the Mugil area of the Sumkar District. A total of 669 children visited the clinic and a total of 1921 illness episodes were recorded. Inclusion criteria were: age between 3 and 27 months, full clinical record (signs/symptoms) and pulse oximetry used systematically to assess sick children at all visits. Children were excluded if they visited the clinic in the previous 14 days. The outcome measures were severe illness, severe pneumonia, pneumonia, defined by the Integrated Management of Childhood Illness (IMCI) definitions, and hospitalization. Out of 1921 illness episodes, 1663 fulfilled the inclusion criteria. A total of 139 severe illnesses were identified, of which 93 were severe pneumonia. The ROC curves of pulse oximetry (continuous variable) showed an AUC of 0.63, 0.68 and 0.65 for prediction of severe illness, severe pneumonia and hospitalization, respectively. Pulse oximetry allowed better discrimination between severe and non-severe illness, severe and non-severe pneumonia, admitted and non-admitted patients, in children ≤12-months of age relative to older patients. For the threshold of peripheral arterial oxygen saturation ≤ 94% measured by pulse oximetry (SpO2), unadjusted odds ratios for severe illness, severe pneumonia and hospitalization were 6.1 (95% Confidence Interval (CI) 3.9–9.8), 8.5 (4.9–14.6) and 5.9 (3.4–10.3), respectively. Pulse oximetry was helpful in identifying children with severe illness in outpatient facilities in PNG. A SpO2 of 94% seems the most discriminative threshold. Considering its affordability and ease of use, pulse oximetry could be a valuable additional tool assisting the decision to admit for treatment.

2 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
JBJulien Blanc
Julien Blanc
JRJonathan Ruggiero
Jonathan Ruggiero
ILIlaria Lucca
Ilaria Lucca
NANicolas Arnold
Nicolas Arnold
BKBernhard Kiss
Bernhard Kiss
BRBeat Roth
Beat Roth
To evaluate hyperthermic intravesical chemotherapy (HIVEC) using conductive heating and epirubicin in an optimized setting as an alternative to radical cystectomy in patients with recurrent non-muscle invasive bladder cancer (NMIBC) who have failed bacillus Calmette-Guérin (BCG) therapy. We retrospectively analyzed our prospectively recorded database of patients who underwent HIVEC between 11/2017 and 11/2022 at two Swiss University Centers. Cox regression analysis was used for univariate/multivariate analysis, and the Kaplan–Meier method for survival analysis. Of the 39 patients with NMIBC recurrence after failed BCG therapy, 25 (64%) did not recur within the bladder after a median follow-up of 28 months. The 12- and 24-month intravesical RFS were 94.8% and 80%, respectively. Extravesical recurrence developed in 14/39 (36%) of patients. Only 7/39 (18%) patients had to undergo radical cystectomy. Seven patients (18%) progressed to metastatic disease, with five of these (71%) having previously developed extravesical disease. No adverse events > grade 2 occurred during HIVEC. Device-assisted HIVEC using epirubicin in an optimized setting achieved excellent RFS rates in this recurrent NMIBC population at highest risk for recurrence after previously failed intravesical BCG therapy. Extravesical disease during or after HIVEC, however, was frequent and associated with metastatic disease and consecutively poor outcomes.

30 May 2021 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
JBJulien Blanc
Julien Blanc
BRBeat Roth
Beat Roth
Background: Clear cell renal carcinoma is known for its propensity for metastatic spread. Common sites of metastasis are the lungs, bones, lymph nodes, liver, adrenals and brain, but all organs can be affected. Contralateral ureteral metastasis is a rare phenomenon, and only a few cases have been reported in the literature. Case presentation: We present the case of a 58-year-old Caucasian patient with a single contralateral ureteral metastasis of a clear cell renal carcinoma. Conclusion: Ureteral metastasis of clear cell renal carcinoma is very rare, and there is no well-established treatment. For patients with low metastatic spread/volume, the aim should be to preserve kidney function, and thus metastasectomy should be considered.

29 April 2021 in REPOCS - Revista Pós Ciências Sociais
Verified
Journal Article
Open access
PDF file
JBJulien Blanc
Julien Blanc
Este artigo analisa as trajetórias de conversão para agricultura orgânica de agricultores familiares localizados na região metropolitana de São Paulo durante os anos 1990 e 2000. Esta conversão ocorreu sob o impulso inicial de indivíduos ligados ao movimento da teologia da libertação e depois da estruturação posterior de um mercado regional em torno da grande distribuição. O texto mostra como a integração desses agricultores em um sistema de mercado regido por lógicas capitalistas foi acompanhada, localmente, por uma profissionalização da agricultura e pela implantação de lógicas e estruturas empresariais. Mostra também como estas dinâmicas de modernização ecológica, embora contribuindo para a geração de uma nova elite rural e de novas formas de desigualdade social, parecem ao mesmo tempo poder contribuir para a manutenção da agricultura em um contexto de forte pressão urbana, para o retorno dos jovens a esta atividade e para a construção de territórios de qualidade ecológica. Nesse sentido, ele indaga se existiriam contextos nos quais a modernização ecológica seria um compromisso aceito por defensores de uma alternativa mais radical? Qualquer que seja a resposta a essa pergunta, a demonstração aqui proposta sublinha a importância de reintegrar a análise das trajetórias ecológicas agrícolas em um estudo mais geral das mudanças sociais, particularmente em seus componentes locais.AbstractThis paper analyzes small farmers’ trajectories in converting to organic farming in the metropolitan region of São Paulo during the 1990s and 2000s. The conversion occurred under the initial push of individuals connected the movement of the Theology of Liberation and after the structuring of a regional market around large-scale distribution. The paper shows how the integration of these farmers in a market system ruled by capitalist logic was accompanied, at the local level, by the professionalization of agriculture and by the implantation of corporate structures and logic. It also shows how these ecologic modernization dynamics, while contributing to the creation of a new rural elite and new forms of social inequality, seem to also be able to contribute to the maintenance of farming in a context of strong urban pressure, to the return ofyoung people to farming, and the construction of territories of ecologic quality.In this sense, it questions whether contexts exist in which ecologic modernization would be a compromise accepted by defenders of more radical alternatives? Whichever the answer to this question, the answer we propose underlines the importance of reintegrating the analysis of the ecologic farming trajectories to a broader study of social changes, mainly in its local components.

20 October 2021 in Urologie in der Praxis
Verified
Journal Article
Open access
PDF file
JBJulien Blanc
Julien Blanc
BRBeat Roth
Beat Roth
ARArnas Rakauskas
Arnas Rakauskas
Résumé: La gynécomastie est fréquemment retrouvée dans la pratique clinique de l’urologue ou du médecin généraliste. D’un point de vue physiopathologique, elle résulte d’un déséquilibre entre la concentration des œstrogènes et des androgènes. De multiples pathologies et traitements peuvent amener à cette perte d’équilibre. Il est important pour le clinicien de reconnaitre les signes de danger qui doivent faire suspecter une néoplasie maligne primaire du tissus mammaire ou secondaire ayant amené à la gynécomastie. Un bilan biologique de base permet le plus souvent de trouver la cause de la gynécomastie. Le traitement est le plus souvent sa cause. Pour certain cas particulier un traitement par le tamoxifène ou la radiothérapie peut être proposé. La chirurgie intervient lors de l’échec du traitement conservateur.

10 August 2026 in Bladder Cancer
Verified
Journal Article
Open access
NANicolas Arnold
Nicolas Arnold
JBJulien Blanc
Julien Blanc
ILIlaria Lucca
Ilaria Lucca
MVMihai Dorin Vartolomei
Mihai Dorin Vartolomei
LSLaila Schneidewind
Laila Schneidewind
BRBeat Roth
Beat Roth
Background: Guidelines recommend intravesical Bacillus Calmette-Guérin (BCG) as adjuvant therapy for intermediate- and high-risk non-muscle-invasive bladder cancer after transurethral resection. In the event of BCG failure, hyperthermic intravesical chemotherapy (HIVEC) represents a treatment alternative to patients who are surgically inoperable, or decline radical cystectomy. Objective: The aim of this study was to evaluate oncological outcomes in patients receiving epirubicin-based HIVEC as a second-line therapeutic approach. Methods: Retrospective inclusion of patients from our prospectively maintained, multicenter HIVEC database, who underwent HIVEC due to recurrent or persistent high-grade NMIBC following adequate BCG therapy (BCG failure) between November 2016 and December 2024. Survival was evaluated using Kaplan–Meier analysis and log-rank testing. Associations between clinicopathological factors and oncological outcomes were assessed using Cox regression analysis. Results: Sixty-five patients were included. Median follow-up was 38 months (IQR 21–55). Twenty-four patients (36.9%) experienced intravesical recurrence with a median intravesical recurrence-free survival (RFS) of 24 months (IQR 9-45) and 1-/2-year intravesical RFS rates of 77.9% and 64.1%, respectively. Extravesical recurrence was observed in 21 patients (32.3%) with a median extravesical RFS of 22 months (IQR 7-43) and 1-/2-year extravesical RFS rates of 81.3% and 70.9%, respectively. Higher number of recurrences prior to HIVEC were significantly associated with extravesical recurrence in univariate (HR 2.23; 95% CI 1.23-3.87; p=0.019) and multivariate analysis (HR 1.31; 95% CI 1.03-1.67; p=0.027). Conclusions: Although limited by the relatively small sample size, Epirubicin-based HIVEC demonstrated promising oncological outcomes indicating its potential value as bladder-preserving treatment option after BCG failure. Prospective controlled studies are warranted to further assess the role of epirubicin-based HIVEC in this setting.